Multicenter observational study of erlotinib therapy (OBSTAR) for non small-cell lung cancer: A GFPC study

Abstract Context Erlotinib therapy for non small-cell lung cancer (NSCLC) has mainly been evaluated in randomized trials. Method OBSTAR was a multicenter, retrospective, observational study involving all patients treated with erlotinib in 18 French centers between June 2005 and September 2007. The a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lung cancer (Amsterdam, Netherlands) Netherlands), 2011-11, Vol.74 (2), p.264-267
Hauptverfasser:	Vergnenègre, A, Monnet, I, Chouaïd, C, Hureaux, J, Mazières, J, Quéré, G, Lombard, J.N, Cumin, I, Abdiche, S, Ejnaini, C. Nocent, Bonnabau, H, Decroisette, Ch
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Factors Aged Aged, 80 and over Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Biological and medical sciences Carcinoma, Non-Small-Cell Lung - diagnosis Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - physiopathology Disease Progression Disease-Free Survival Erlotinib Erlotinib Hydrochloride Female Follow-Up Studies France Hematology, Oncology and Palliative Medicine Humans Life Sciences Lung Neoplasms - diagnosis Lung Neoplasms - drug therapy Lung Neoplasms - mortality Lung Neoplasms - pathology Lung Neoplasms - physiopathology Male Medical sciences Middle Aged Neoplasm Metastasis Neoplasm Staging Observational study Pneumology Prognosis Pulmonary/Respiratory Quinazolines - administration & dosage Quinazolines - adverse effects Retrospective Studies Risk Factors Santé publique et épidémiologie Sex Factors Smoking Stage IV NSCLC Survival Analysis Tumors Tumors of the respiratory system and mediastinum Withholding Treatment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!